Computer-aided detection software developed by R2 Technology can now be marketed as an integral part of the GE Senographe 2000D full-field digital mammography system, following FDA approval. This is the latest step in R2's pioneering efforts to make CAD
Computer-aided detection software developed by R2 Technology can now be marketed as an integral part of the GE Senographe 2000D full-field digital mammography system, following FDA approval. This is the latest step in R2's pioneering efforts to make CAD a routine part of medical practice. The FDA approved the company's ImageChecker, a stand-alone CAD workstation, in 1998 for use with film-based screening mammography. Three years later the FDA expanded approval to include its use with diagnostic mammograms. R2 has shipped more than 400 film and digital-based systems worldwide. More than three million women have had their mammograms interpreted with the aid of the ImageChecker CAD system. Nearly 300 Senographe 2000D systems have been installed in the U.S. All are upgradable to R2's CAD technology.
Radiology Experience, Breast Density and Screening Mammography: What New Research Reveals
October 4th 2024In a study looking at the impact of experience and case volume of breast screening radiologists, researchers found that reviewing more than 150 cases per week was necessary to achieve an 80 percent rate of true-positive assessments for malignant calcifications.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.